A Bayesian multi‐risks survival (MRS) model in the presence of double censorings
From MaRDI portal
Publication:6047772
DOI10.1111/biom.13228zbMath1520.62176OpenAlexW3004278418WikidataQ93020959 ScholiaQ93020959MaRDI QIDQ6047772
No author found.
Publication date: 9 October 2023
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.13228
MCMC methodsmultistate modeltime-to-event datasemi-competing risksprostate cancer dataBayesian model selection criteria
Cites Work
- Unnamed Item
- Unnamed Item
- Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching
- Maximum likelihood inference for the Cox regression model with applications to missing covariates
- Monte Carlo methods in Bayesian computation
- Bayesian path specific frailty models for multi-state survival data with applications
- Competing Risks and Multistate Models with R
- Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study
- Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model
- The Analysis of Failure Times in the Presence of Competing Risks
- A Predictive Approach to Model Selection
- The Collapsed Gibbs Sampler in Bayesian Computations with Applications to a Gene Regulation Problem
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- A New Bayesian Model for Survival Data with a Surviving Fraction
- Bayesian Measures of Model Complexity and Fit
- Adaptive Rejection Sampling for Gibbs Sampling
- On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data
